Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cosar Pharmaceutical is a prominent Iranian pharmaceutical manufacturer specializing in the production of a wide range of generic human medicines. The company is particularly recognized for its extensive portfolio of antibiotics, including penicillins and cephalosporins, produced in dedicated, high-capacity manufacturing facilities. Beyond anti-infectives, Cosar develops and markets treatments for cardiovascular, gastrointestinal, and metabolic conditions. The company operates under strict Good Manufacturing Practice (GMP) standards and serves both the domestic Iranian market and various export regions in the Middle East and Central Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cosar Pharmaceutical.